What is included in medical care for immunodeficiency in patients with coxsackievirus infections?

Updated: Aug 24, 2018
  • Author: Martha L Muller, MD, MPH; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print
Answer

Both IVIG and pleconaril have been used in immunocompromised patients with enteroviral infections (neonates and B-cell immunodeficient) with varying success.

In vitro studies have suggested that arbidol may have potential as a future antiviral agent with activity against coxsackievirus, but no trials in humans have yet been performed. [10]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!